Non‐responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions
AUTOR(ES)
Lux, Anja
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2000982Documentos Relacionados
- Blood pressure distribution in responders and initial non-responders in a population screening study.
- Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin)
- Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)
- Low intensity extracorporeal shockwave Therapy shifts PDE5i nonresponders to responders
- Continuous opportunistic and systematic screening for hypertension with computer help: analysis of non-responders.